Innate Pharma (IPHA) Times Interest Earned (2019 - 2025)
Innate Pharma (IPHA) posted quarterly Times Interest Earned of $16.76 for Q4 2025, up 24.66% year-on-year from $13.45 in Q4 2024, and up 297.96% on a QoQ basis from -$8.47 in Q2 2025.
Innate Pharma (IPHA) Times Interest Earned (2019 - 2025) Analysis & Trends
Innate Pharma (IPHA) has reported Times Interest Earned for 7 consecutive years, with $16.76 the latest figure, recorded in Q4 2025.
- Quarterly Times Interest Earned rose 24.66% year-over-year to $16.76 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4374.5 (down 1121.09% YoY) and the FY2025 annual result came in at -$17.31, down 33.41% from the prior year.
- Times Interest Earned improved to $16.76 in Q4 2025 per IPHA's latest filing, from -$8.47 in the prior quarter.
- Over the last five years, Times Interest Earned for IPHA reached as high as $3087.8 in Q4 2022 and fell as low as -$8.47 in Q2 2025.
- A 5-year average of $390.01 and a median of $8.55 in 2021 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned surged 25706.67% — and 2024, when it slumped 2994.25%.
- Year by year, Times Interest Earned stood at $11.97 in 2021, then jumped by 25706.67% to $3087.8 in 2022, then sank by 99.83% to $5.13 in 2023, then surged by 162.33% to $13.45 in 2024, then increased by 24.66% to $16.76 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered $16.76, -$8.47, and $13.45 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Innate Pharma | 157.68 Mn | 157.68 Mn | - | 16.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.76 |
| Jun 30, 2025 | -8.47 |
| Dec 31, 2024 | 13.45 |
| Jun 30, 2024 | -6.37 |
| Dec 31, 2023 | 5.13 |
| Jun 30, 2023 | -0.21 |
| Dec 31, 2022 | 3,087.83 |
| Dec 31, 2021 | 11.97 |
| Dec 31, 2020 | 1.12 |
| Dec 31, 2019 | 5.17 |